Yifan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products, raw materials, and polymer materials in Southeast Asia, Europe and North America, Singapore, South Korea, Italy, China, Germany, and the United States. It offers Chinese patent medicines, chemical medicines and biological medicines; and vitamin products, including vitamin B5 and original B5. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan Pharmaceutical Co., Ltd. in October 2016. Yifan Pharmaceutical Co., Ltd. was founded in 2000 and is headquartered in Hangzhou, China.
Metrics to compare | 002019 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002019PeersSector | |
---|---|---|---|---|
P/E Ratio | 38.7x | 26.2x | −0.7x | |
PEG Ratio | 0.19 | 0.30 | 0.00 | |
Price/Book | 1.9x | 3.1x | 2.6x | |
Price / LTM Sales | 3.3x | 4.1x | 3.4x | |
Upside (Analyst Target) | 29.8% | 23.7% | 35.7% | |
Fair Value Upside | Unlock | 10.1% | 4.1% | Unlock |